Simpkins Fiona - Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA, United States.

基本信息

浏览量：23

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 18 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR

Haineng Xu, Erin George,David Gallo,Sergey Medvedev, Xiaolei Wang, Rosie Kryczka,Marc L Hyer,Jimmy Fourtounis, Rino Stocco, Elia Aguado-Fraile, Adam Petrone, Shou Yun Yin,

Research square (2024)

引用0浏览0WOS引用

Molecular landscape and clinical outcomes of ARID1A mutant ovarian and endometrial cancers (2276)

Leslie Andriani,Erin George,Sharon Wu,Joanne Xiu,Jamie Holloway,Thomas Herzog,Premal Thaker,W. Michael Korn,Noam Auslander,Nathaniel Jones,Eric Brown,Emily Ko,

Gynecologic Oncology (2023): S301-S302

引用0浏览0引用

Abstract 6177: ATRN-119 and ATRN-W1051: Novel and potentially well tolerated ATR and WEE1 inhibitors for targeted cancer treatment

Joseph P. Vacca, Stephen Rocca, Justin Frye, Steven J. Schnell, Molly Hansbarger, Gregory A. Korbel,Fiona Simpkins,Eric J. Brown, Oren Gilad

Cancer Researchno. 7_Supplement (2023): 6177-6177

引用0浏览0引用

A B7-H4 targeting antibody-drug conjugate shows anti-tumor activity in PARPi and platinum resistant cancers with B7-H4 expression

Sarah B. Gitto,Margaret Whicker, Gareth Davies,Sushil Kumar,Krista Kinneer,Arthur Lewis, Srinivas Mamidi,Sergey Medvedev, Judith Anderton, Jessica Tang,Benjamin Ferman,Steve Coats,

CANCER RESEARCHno. 7 (2023): 1133-1133

引用0浏览0WOS引用

ATRN-119 and ATRN-W1051: Novel and potentially well tolerated ATR and WEE1 inhibitors for targeted cancer treatment

Joseph Vacca, Stephen Rocca, Justin Frye, Steven J. Schnell, Molly Hansbarger, Gregory Korbel,Fiona Simpkins,Eric J. Brown, Oren Gilad

CANCER RESEARCHno. 7 (2023)

引用0浏览0引用

Role of immunotherapy for lymph-node positive vulvar melanoma: Utilization and outcomes (154)

Dimitrios Nasioudis,Nawar Latif,Ashley Haggerty,Lori Cory, Robert Giuntoli,Sarah Kim,Fiona Simpkins,Emily Ko

Gynecologic Oncologyno. 9 (2022): S93-S93

引用0浏览0引用

EP263/#849 Olaparib treatment in patients with platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: characterization of long-term/short-term treatment duration in light

Ying Liu,Cara Mathews,Fiona Simpkins,Karen Cadoo,Diane Provencher,Colleen Mccormick, Adam Einaggar,Alon Altman,Lucy Gilbert,Destin Black,Nashwa Kabil, Rosie Taylor,

E-Posters (2022): A156-A157

引用0浏览0引用

Olaparib treatment (Tx) in patients (pts) with platinum-sensitive relapsed ovarian cancer (PSR OC) by BRCA mutation (BRCAm) and homologous recombination deficiency (HRD) status: Overall survival (OS) results from the phase II LIGHT study

Cara Amanda Mathews,Fiona Simpkins,Karen Anne Cadoo,Ying L. Liu,Diane M. Provencher,Colleen McCormick,Adam ElNaggar,Alon D. Altman,Lucy Gilbert, Destin Black, Nashwa Kabil,James Bennett,

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用2浏览0引用

Olaparib Treatment In Patients With Platinum-Sensitive Relapsed Ovarian Cancer By Brca Mutation And Homologous Recombination Deficiency Status: Secondary Safety Results From The Phase Ii Light Study

Karen Cadoo,Fiona Simpkins,Cara Mathews,Alon Altman,Lucy Gilbert,Ying Liu,Destin Black,Jiefen Munley,Nashwa Kabil,James Bennett,Hong Yu,Carol Aghajanian

GYNECOLOGIC ONCOLOGY（2021）

引用3浏览0引用

Brca変異と相同組換え欠損状態による白金感受性再発卵巣癌患者におけるオラパリブ治療:第ii相light研究からの二次有効性結果【jst・京大機械翻訳】

Cadoo Karen,Simpkins Fiona,Mathews Cara, Liu Ying, Provencher Diane, McCormick Colleen, ElNaggar Adam, Kabil Nashwa,Bennett James, Yu Hong, Munley Jiefen,Aghajanian Carol

Gynecologic Oncology (2021): 217

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn